Literature DB >> 34509401

Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.

P C Bello-Medina1, D A González-Franco2, I Vargas-Rodríguez1, S Díaz-Cintra3.   

Abstract

INTRODUCTION: Worldwide, approximately 50 million people have dementia, with Alzheimer disease (AD) being the most common type, accounting for 60%-70% of cases. Given its high incidence, it is imperative to design studies to expand our knowledge about its onset and development, and to develop early diagnosis strategies and/or possible treatments. One methodological strategy is the use of transgenic mouse models for the study of the factors involved in AD aetiology, which include oxidative stress and the immune response. DEVELOPMENT: We searched the PubMed, Scopus, and Google Scholar databases for original articles and reviews published between 2013 and 2019. In this review, we address 2 factors that have been studied independently, oxidative stress and the immune response, in transgenic models of AD, and discuss the relationship between these factors and their impact on the loss of synaptic and structural plasticity, resulting in cognitive impairment.
CONCLUSION: This review describes possible mechanisms by which oxidative stress and the immune response participate in the molecular, cellular, and behavioural effects of AD, observing a close relationship between these factors, which lead to cognitive impairment.
Copyright © 2019 Sociedad Española de Neurología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  3xTg-AD; Alzheimer; Free radicals; Hipocampo; Hippocampus; Microglia; Microglía; Plasticidad sináptica; Radicales libres; Synaptic plasticity

Mesh:

Year:  2021        PMID: 34509401     DOI: 10.1016/j.nrleng.2019.06.008

Source DB:  PubMed          Journal:  Neurologia (Engl Ed)        ISSN: 2173-5808


  2 in total

Review 1.  Microglia-Mediated Inflammation and Neural Stem Cell Differentiation in Alzheimer's Disease: Possible Therapeutic Role of KV1.3 Channel Blockade.

Authors:  Miren Revuelta; Janire Urrutia; Alvaro Villarroel; Oscar Casis
Journal:  Front Cell Neurosci       Date:  2022-04-21       Impact factor: 5.505

2.  Maackiain Prevents Amyloid-Beta-Induced Cellular Injury via Priming PKC-Nrf2 Pathway.

Authors:  Na Lu; Guojun Tan; Hongling Tan; Xing Zhang; Yunling Lv; Xiujuan Song; Daofeng You; Ziyuan Gao
Journal:  Biomed Res Int       Date:  2022-06-22       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.